« Back to Record
Citation APA

Desmedt, C., Haibe-Kains, B., de Azambuja, E., Larsimont, D., Delaloge, S., Duhem, C., Di Leo, A., D'Hondt, V., Piccart-Gebhart, M., & Sotiriou, C. (2009). Gene expression signatures can predict the efficacy of anthracyclines in HER2-negative and HER2-positive breast cancer (BC) patients: The results of the TOP trial and their validation in the BIG1-00 trial. Annals of Oncology. Vol. vol 20 Suppl 2 (p. ii45) Abstract session presented at IMPAKT Breast Cancer Conference(May 7-9, 2009: Brussels, Belgium).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/154768

Desmedt, C., Haibe-Kains, B., de Azambuja, E., Larsimont, D., Delaloge, S., Duhem, C., Di Leo, A., D'Hondt, V., Piccart-Gebhart, M., & Sotiriou, C. (2009). Gene expression signatures can predict the efficacy of anthracyclines in HER2-negative and HER2-positive breast cancer (BC) patients: The results of the TOP trial and their validation in the BIG1-00 trial. Annals of Oncology. Vol. vol 20 Suppl 2 (p. ii45) Abstract session presented at IMPAKT Breast Cancer Conference(May 7-9, 2009: Brussels, Belgium).